24.5
亲和力
概观
抗体与细胞、细菌、病毒或真菌表面的毒素或物质结合。该物质被称为抗原，精确的结合位点是表位。抗体 - 表位相互作用的强度称为亲和力。当抗体通过多个表位结合抗原时，相互作用的累积强度称为亲合力。相互作用的强度影响引发的免疫反应。“
适应性免疫系统通过提高抗体亲和力提高效率
根据定义，抗体所能结合的…
在免疫反应期间， 抗体通过与称为抗原的病原体 表面上的特定蛋白质结合 来靶向并破坏外来病原体。 这些抗体 - 抗原相互作用 对于防止病原体 感染其他细胞和标记病原体 进行破坏至关重要。 这里，术语亲和力是指 单个抗体与单个表位 或抗原的一部分之间的 相互作用的强度。
例如，对特定抗原具有 高亲和力的抗体 将具有强烈且稳定的相互作用， 防止分离。 相反，低亲和力相互作用 将容易分裂。 不同程度的抗体亲和力 允许免疫系统优化它对特定病原体 如普通感冒病毒的反应。
例如，免疫系统第一次 遇到病原体， 抗体 - 抗原相互作用的亲和力 可能很低。 但是，反复暴露于同一抗原 将使宿主产生具有增加的 亲和力的抗体 发挥更强，更快的免疫反应。 一些抗体可以同时结合 多个抗原表位， 因为它们是多价的。 在这种情况下，这些相互作用的 累积强度称为亲合力。 通常，多价抗体和抗原之间的相互作用 是高亲合力但低亲和力。
View the full transcript and gain access to JoVE Core videos
Q1: What is the difference between affinity and avidity in antibody-antigen interactions?
Affinity measures the strength of interaction between a single antibody and a single epitope on an antigen. Avidity refers to the cumulative binding strength when a multivalent antibody binds multiple epitopes simultaneously. High avidity antibodies typically have low affinity for individual epitopes but achieve strong overall binding through multiple contact points.
Q2: How does antibody affinity change during repeated exposure to the same antigen?
During initial pathogen exposure, antibodies produced have low affinity for the antigen. However, repeated encounters trigger an adaptive selection process that produces antibodies with progressively higher affinity. This affinity maturation results in stronger and faster immune responses upon subsequent exposures to the same pathogen.
Q3: Why do multivalent antibodies like IgM have high avidity but low affinity?
IgM antibodies possess multiple binding sites recognizing the same epitope, creating high cumulative binding strength or avidity. However, individual binding interactions have low affinity. This design allows IgM to quickly recognize new antigens without requiring elaborate selection processes, making it ideal for initial immune responses.
Q4: What role does the epitope play in antibody-antigen binding?
An epitope is the precise binding site on an antigen where an antibody makes contact. The strength of interaction between an antibody and a specific epitope defines that antibody's affinity. Different epitopes on the same antigen can be recognized by different antibodies, allowing varied immune responses.
Q5: How does varying antibody affinity optimize the immune response to pathogens?
Low-affinity antibodies from initial exposures provide basic pathogen recognition and tagging for destruction. As the immune system encounters the same pathogen repeatedly, higher-affinity antibodies are produced, enabling stronger binding, more efficient pathogen neutralization, and faster immune responses during subsequent infections.
Q6: What is the functional advantage of IgM antibodies in early immune responses?
IgM antibodies are produced quickly during early immune responses because they do not undergo elaborate affinity selection processes. Their high avidity compensates for low individual binding affinity, allowing them to recognize new antigens effectively. IgM also triggers B cells to produce other antibody classes with higher affinity against newly identified antigens.
Q7: How do antibodies prevent pathogen infection and facilitate destruction?
Antibodies bind to antigens on pathogen surfaces through antibody-antigen interactions, preventing the pathogen from infecting other cells. Simultaneously, these bound antibodies tag pathogens for destruction by immune system components. The strength of these interactions, determined by affinity and avidity, directly influences the effectiveness of the immune response.